Sarepta Therapeutics (SRPT) Posts Wider Q4 Loss; NDA Submission for Eteplirsen Planned for Mid-Year 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. DPZ
4. ACN
5. IBM
6. META
7. PLTR
8. MSFT
9. MHTLY
10. NAVN

Go back to Sarepta Therapeutics (SRPT) Posts Wider Q4 Loss; NDA Submission for Eteplirsen Planned for Mid-Year 2015
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.65 --0 (-0%)
Previous Close $17.65    52 Week High $63.73 
Open $17.65    52 Week Low $8.00 
Day High $17.65    P/E N/A 
Day Low $17.65    EPS $-5.69 
Volume 2,164